Full Data
?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets
Join Now!
Need this critical market data?
Access thousands of market events, data points, and news articles!
Already have an account?
Login
Home » News » "New crown drug" Qianjintiansu drives the stock price limit of many traditional Chinese medicine companies. The inventor responded: it has nothing to do with us-Stock Channel-Hexun Network